Status:
UNKNOWN
Effectiveness Of Mobile Application To Improve Adherence To Tuberculosis Treatment
Lead Sponsor:
Mohd Fazeli bin Sazali
Collaborating Sponsors:
Ministry of Health, Malaysia
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tuberculosis (TB) is a major public health concern, where it is among the top ten causes of death and the leading cause of death due to a single infectious agent globally. Providing standard anti-TB t...
Detailed Description
Background Tuberculosis (TB) is an infectious disease that is caused by a bacterium called Mycobacterium tuberculosis. Worldwide, TB is considered as one of the major public health threats, where it i...
Eligibility Criteria
Inclusion
- Newly diagnosed and all existing TB cases in maintenance phase.
- Age 18 years old and above
- Receiving standard therapy of daily antituberculosis drug according to Malaysian Clinical Practice Guideline of Tuberculosis 3rd Edition 2011.
Exclusion
- No access to smart phone
- On injectable type of anti-TB
- Less than two months remaining in current treatment regime.
- Not planned to continue follow ups in study location in the next two months.
- Patients with psychiatric problem and no family members to assist taking medication at home.
- Not being able to understand Malay and English language
- Patients that health care staff consider needed intensive face-to-face support for emotional, medical, or structural reasons, as well as imminent risk of loss to follow up.
- Unconsented to participate
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 28 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05259254
Start Date
June 1 2022
End Date
May 28 2023
Last Update
November 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohd Fazeli bin Sazali
Kota Kinabalu, Sabah, Malaysia, 88450